AN UPDATED MIXED TREATMENT COMPARISON OF BIOLOGIC TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

被引:0
|
作者
Rodriguez, M. F. [1 ]
Balmaceda, C. [1 ]
Espinoza, M. A. [1 ]
Rojas, R. [1 ]
Vargas, C. [1 ,2 ]
Dominguez, A. [1 ]
Duran, J. [1 ]
机构
[1] Pontificia Univ Catolica Chile, Santiago, Chile
[2] Univ Technol Sydney, Sydney, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
506
引用
收藏
页码:S95 / S96
页数:2
相关论文
共 50 条
  • [1] Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis
    Desai, Rishi J.
    Hansen, Richard A.
    Rao, Jaya K.
    Wilkins, Tania M.
    Harden, Elizabeth A.
    Yuen, Andrea
    Jonas, Daniel E.
    Roubey, Robert
    Jonas, Beth
    Gartlehner, Gerald
    Lux, Linda
    Donahue, Katrina E.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1491 - 1505
  • [2] Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
    Bergman, Gert J. D.
    Hochberg, Marc C.
    Boers, Maarten
    Wintfeld, Neil
    Kielhorn, Adrian
    Jansen, Jeroen P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (06) : 425 - 441
  • [3] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S110 - S110
  • [4] Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia
    Machado-Alba, J. E.
    Ruiz, A. F.
    Machado-Duque, M. E.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (06) : 506 - 511
  • [5] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Mittal, Niti
    Mittal, Rakesh
    Sharma, Aman
    Jose, Vinu
    Wanchu, Ajay
    Singh, Surjit
    [J]. SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536
  • [6] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
    Choy, Ernest
    Freemantle, Nick
    Proudfoot, Clare
    Chen, Chieh-I
    Pollissard, Laurence
    Kuznik, Andreas
    van Hoogstraten, Hubert
    Mangan, Erin
    Carita, Paulo
    Thi-Minh-Thao Huynh
    [J]. ADVANCES IN THERAPY, 2019, 36 (04) : 817 - 827
  • [7] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
    Ernest Choy
    Nick Freemantle
    Clare Proudfoot
    Chieh-I Chen
    Laurence Pollissard
    Andreas Kuznik
    Hubert van Hoogstraten
    Erin Mangan
    Paulo Carita
    Thi-Minh-Thao Huynh
    [J]. Advances in Therapy, 2019, 36 : 817 - 827
  • [9] Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
    Xia, Yunfei
    Yin, Rulan
    Fu, Ting
    Zhang, Lijuan
    Zhang, Qiuxiang
    Guo, Genkai
    Li, Liren
    Gu, Zhifeng
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 735 - 742
  • [10] Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs
    Sizova, Lyudmila
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 173 - 178